Current manual methods for HER2 assessment are fraught with challenges. Significant challenges are the inter- and intra-reader variability and the high proportion of inconclusive cases requiring additional testing for a definitive diagnosis. These inconclusive cases pose a considerable challenge, adding costs for reflex testing, and slowing down the diagnostic process, thereby creating uncertainty for patients and clinicians alike. In this context, AI-driven precision pathology has emerged as a promising solution 💡 Read our whitepaper to learn more about Visiopharm’s IVDR-cleared solution for HER2 assessment: https://hubs.ly/Q02ljrBn0
Visiopharm’s Post
More Relevant Posts
-
Watch our latest webinar featuring Akash P. from HistoWiz, as he explores recent advancements in the development of automated QC tools that are leading the way to accelerate pathology discovery. https://hubs.la/Q02jJDSR0
-
-
Digital Pathology Market to Exceed USD 2.3 billion by 2035, Due to the Growing Demand for Advanced Diagnosing Procedures| Roots Analysis: LONDON , Dec. 4, 2023 /PRNewswire/ -- According to a recently published report by Roots Analysis, the growing preference for advanced diagnostic tools and technology for quick disease diagnosis is driving the growth of the digital pathology market. Digital Pathology Market Overview The...
-
Dear Author, we would be delighted to have your expertise published on Diagnostic Pathology Open Access! Please consider submitting an article with us to share your valuable insights. #DiagnosticPathology #OpenAccess #ResearchCommunity #AuthorsOfTwitter #callforpapers
-
-
Thought-provoking insights on patient-centered clinical pathways shared by Martin Myers MBE! We are delighted to have Martin speaking on this all-important topic of Getting it Right First Time (GIRFT) at our upcoming Pathology Horizons conference from 18th-20th April. Don't miss out on your chance to join in on this valuable discussion. Regsiter here: https://lnkd.in/gx9vZbew #PathologyHorizons2024 #pathologyhorizons #pathology #GIRFT #bath #conference #futureofpathology
Consultant Clinical Biochemist, Joint Clinical Lead at NHSE Getting it Right First Time (GIRFT), Pathology. Laboratory Director Clinical Biochemistry & Clinical Lead for POCT at Lancashire Teaching Hospital @Martin1Myers
A Diagnostic Revolution indeed. Pathology needs to be delivered wherever it is needed for the patient, not where it is needed by Pathology staff! Laboratory Anywhere is about patient-focused diagnostics, and point of care testing will enable improved patient pathways. Exciting times.i
-
-
CEO @ assaya | Digitizing, quantifying and standardising Lateral Flow assay-based Rapid Diagnostic Test results for Antigens, Antibodies and Biomarkers for accessibility & affordability at decentralised scale. #OneHealth
#LaboratoryAnywhere, a succinct description by Martin Myers MBE augmenting traditional, centralized laboratory models towards a more distributed, accessible, and patient-centric approach. This approach can leverage technological advancements and digital health solutions to bring diagnostic services directly to patients, no matter where they are. Decentralization Diagnostic Services in the future. Point-of-Care Testing or Point-of-Exam Testing: Diagnostic tests are conducted at or near the point of patient care, such as in community clinics, pharmacies, or even at the patient's home, using portable and easy-to-use devices. Mobile Health Units: Mobile labs or clinics equipped with diagnostic facilities can reach remote or underserved areas, providing essential health services without patients needing to travel to hospital-based labs. #REASSURED - https://lnkd.in/gZsJPdEj #Healthcare #DigitalHealthCare #Diagnostics #POCT #POC #POET #Decentralised
Consultant Clinical Biochemist, Joint Clinical Lead at NHSE Getting it Right First Time (GIRFT), Pathology. Laboratory Director Clinical Biochemistry & Clinical Lead for POCT at Lancashire Teaching Hospital @Martin1Myers
A Diagnostic Revolution indeed. Pathology needs to be delivered wherever it is needed for the patient, not where it is needed by Pathology staff! Laboratory Anywhere is about patient-focused diagnostics, and point of care testing will enable improved patient pathways. Exciting times.i
-
-
Time for some daily med-tech inspiration? 🦾 Dr. Fiona Maclean sheds light on the importance of a correct diagnosis, and how time is everything in a global pathology shortage 🌏 Fiona explains in a recent World Shapers event how the biggest and best outcome from this new technology is getting more accurate and timely diagnosis ⏳ You can catch more insights from Fiona in the full session here https://lnkd.in/gNutH47B 🌐 #pathology #healthcare #artificialintelligence #technology
-
-
Interested in digital pathology but struggling with implementation? Get the inside scoop on seamless implementation and unlock the full potential of digital at our annual Digital Diagnostic Summit. Don't miss out on this opportunity! Learn more and register here: https://lnkd.in/ggqzxA2x #DigitalPathology #DDXSummit
-
-
In the realm of #standardizedtesting within speech-language pathology, the standard score is often the first metric we encounter. But what insights does it truly offer us about our clients? The standard score is derived from the raw score and adjusted to fit the normal distribution curve, with a mean of 100 and a standard deviation of 15. A score of 85, for instance, places a client one standard deviation below the mean. It's a crucial data point, yet it's merely a single snapshot influenced by numerous factors during the testing process. As we delve deeper into the various scores obtained from standardized tests, we must critically evaluate their utility. Is the standard score the most effective tool for interpretation? How does it shape our diagnostic decision-making? Join us in this comprehensive exploration of test scores and their implications. Engage with us, share your experiences, and let's enhance our collective understanding. Your perspective is invaluable. 👉 Visit our website to subscribe to our newsletter for more in-depth discussions and insights. #StandardizedTesting #SpeechLanguagePathology #DiagnosticDecisionMaking #ClinicalAssessment
-
Using diagnostic imaging tools of soft tissue in breast cancer-related lymphedema helps identify areas that require high pressure for volume reduction and evaluates the alterations in tissue texture. Check out our MOH Talk with Linda T. Miller and Vincent Singh Paramanandam, PhD and find out more about the diagnosis and treatment approaches of breast cancer-related lymphedema: https://lnkd.in/dytiXkih #MOH #HealthCare #SigvarisGroup #lymphedema
-
Host of the Pod of Inquiry Video Podcast| CEO and Medical Director US Neuropathy Centers| Inventor of the Endoscopic Plantar Fasciotomy Technique| Top 50 Most Influential Podiatrists| Editorial Board Open J Orthopedics
I encourage everyone who is dealing with lower extremity nerve pathology to start implementing this powerful diagnostic and prognostic peripheral nerve block into their practice. The full video can be seen at: https://lnkd.in/gamJDM3S
